Qu'est-ce qu'une franchise en assurance santé ?

C'est le montant que le patient doit payer avant que l'assurance ne couvre les frais.

Comment fonctionne la coassurance ?

C'est le pourcentage des frais médicaux que le patient doit payer après la franchise.

Quelle est la différence entre franchise et coassurance ?

La franchise est un montant fixe, tandis que la coassurance est un pourcentage des frais.

Comment sont calculées les franchises ?

Elles sont généralement fixées par le contrat d'assurance et varient selon les plans.

Les franchises sont-elles remboursables ?

Non, les montants de franchise ne sont pas remboursés par l'assurance.

Quels sont les impacts d'une franchise élevée ?

Une franchise élevée peut dissuader les patients de consulter des soins médicaux.

Comment la coassurance affecte-t-elle les patients ?

Elle peut entraîner des coûts supplémentaires pour les patients lors de soins médicaux.

Les patients ressentent-ils du stress à cause des franchises ?

Oui, les coûts imprévus peuvent causer de l'anxiété financière chez les patients.

Les franchises influencent-elles la santé des patients ?

Elles peuvent limiter l'accès aux soins, affectant ainsi la santé globale des patients.

Y a-t-il des symptômes financiers liés à la coassurance ?

Oui, des frais médicaux imprévus peuvent entraîner des difficultés financières.

Comment éviter des frais élevés de franchise ?

Choisissez un plan avec une franchise adaptée à vos besoins médicaux prévisibles.

Les bilans de santé sont-ils couverts sans franchise ?

Souvent, les bilans de santé préventifs sont couverts sans frais de franchise.

Comment éduquer les patients sur les franchises ?

Fournissez des informations claires sur les coûts et les options d'assurance disponibles.

Les programmes de prévention réduisent-ils les coûts ?

Oui, ils peuvent réduire les coûts à long terme en évitant des soins coûteux.

Comment les patients peuvent-ils planifier leurs soins ?

Ils doivent évaluer leurs besoins et choisir des soins en fonction de leur plan d'assurance.

Comment choisir un plan avec franchise ?

Évaluez vos besoins médicaux et comparez les coûts des franchises et coassurances.

Les traitements préventifs sont-ils couverts ?

Souvent, les traitements préventifs sont couverts sans franchise, selon le plan.

Comment réduire les coûts de coassurance ?

Choisissez des soins dans le réseau de votre assurance pour réduire les frais.

Les médicaments sont-ils soumis à la franchise ?

Oui, certains médicaments peuvent être soumis à la franchise selon le plan d'assurance.

Les soins d'urgence sont-ils affectés par la coassurance ?

Oui, les soins d'urgence peuvent entraîner des frais de coassurance après la franchise.

Quelles complications peuvent survenir avec des franchises élevées ?

Les patients peuvent retarder des soins nécessaires, entraînant des complications de santé.

La coassurance peut-elle entraîner des complications financières ?

Oui, des frais imprévus peuvent causer des dettes médicales importantes.

Les patients évitent-ils des soins à cause des coûts ?

Oui, les coûts élevés peuvent dissuader les patients de rechercher des soins médicaux.

Comment les complications de santé affectent-elles les coûts ?

Des complications peuvent entraîner des frais médicaux supplémentaires et imprévus.

Les complications dues à la coassurance sont-elles fréquentes ?

Oui, de nombreux patients rencontrent des difficultés à payer leurs frais médicaux.

Quels facteurs augmentent les coûts de franchise ?

L'âge, les antécédents médicaux et le type de soins peuvent influencer les coûts.

Comment le choix de l'assurance affecte-t-il les coûts ?

Différents plans d'assurance ont des franchises et coassurances variées, influençant les coûts.

Les maladies chroniques augmentent-elles les frais ?

Oui, les patients avec des maladies chroniques peuvent faire face à des frais plus élevés.

Les jeunes adultes ont-ils des franchises plus basses ?

Souvent, les jeunes adultes choisissent des plans avec des franchises plus basses.

Les habitudes de santé influencent-elles les coûts ?

Oui, des habitudes de santé positives peuvent réduire les frais médicaux à long terme.

Franchises et coassurance - Informations médicales vérifiées

Intrapartum continuous subcutaneous insulin infusion vs intravenous insulin infusion among pregnant individuals with type 1 diabetes mellitus: a randomized controlled trial.

12 2023

DOI: 10.1016/j.ajog.2023.07.003 PMID: 37429432

Intrapartum glucose management is critical to reducing neonatal hypoglycemia shortly after birth. Although it is known that insulin is required for all pregnant individuals with type 1 diabetes mellit... This study aimed to compare the effect of intrapartum use of continuous subcutaneous insulin infusion with that of intravenous insulin infusion for glucose management among pregnant individuals with t... This was a randomized controlled trial of pregnant participants with type 1 diabetes mellitus. After written informed consent, participants were randomly allocated to 1 of 2 intrapartum insulin admini... Between March 2021 and April 2023, 76 participants were approached, and 70 participants were randomized (35 participants in the intravenous insulin infusion group and 35 participants in the continuous... Pregnant individuals with type 1 diabetes mellitus using either intravenous insulin infusion or continuation of their continuous subcutaneous insulin infusion for intrapartum insulin administration ha...

Pregnancy Infant, Newborn Female Humans Insulin +6 autres

The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspective.

31 Oct 2024

DOI: 10.1186/s12913-024-11719-0 PMID: 39482711

Recent studies have underscored the potential of innovative administration methods to mitigate the capacity burden on healthcare systems, without compromising the quality of care. This study assessed ... In this micro-costing study, data on resource use and time allocation for drug preparation and administration were collected using an observational, non-interventional study design. Data were register... Drug administration through the elastomeric pump resulted in substantially lower healthcare costs when compared to conventional infusion, particularly due to reduced labor and chair time. The elastome... This study demonstrated that the elastomeric pump not only offers substantial cost savings but also enhances the treatment capacity of the oncology day care unit. These findings support the adoption o... This study has been registered in the National Trial Register (NTR), with the reference number NTR NL9473. Registration date: 05-05-2021....

Humans Infusions, Intravenous Immune Checkpoint Inhibitors Infusion Pumps Elastomers

Analysis of transition from intravenous iron sucrose to ferric carboxymaltose infusions in pediatric patients with intestinal failure.

09 2022

DOI: 10.1002/jpen.2412 PMID: 35616288

Iron supplementation is required for pediatric patients with intestinal failure (IF). There is a paucity of literature on optimal iron formulation and outcomes in this patient population that requires... This was a single-center observational cohort study of pediatric patients with IF requiring ongoing intravenous iron supplementation. Patients were transitioned from IS to FCM as iron therapy. Longitu... Twenty-three patients were included. Sixteen received IS and later switched to FCM, five received IS only, and two received FCM only. Most patients' etiology of IF was short bowel syndrome (FCM: 81%, ... IS and FCM infusions both maintained hematologic and iron parameters with no significant difference noted between the two types of iron, though the number of FCM infusions was significantly less. No s...

Anemia, Iron-Deficiency Child Ferric Compounds Ferric Oxide, Saccharated Humans +4 autres

Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: a randomized controlled trial.

09 2023

DOI: 10.1016/j.ajogmf.2023.101064 PMID: 37348816

Iron-deficiency anemia in pregnancy is highly prevalent and presents significant risk to patients. Initial treatment is often with oral medication. We hypothesized that intravenous ferumoxytol would r... This study aimed to investigate whether 2 infusions of intravenous ferumoxytol are superior to the use of twice-daily oral ferrous sulfate for the treatment of iron-deficiency anemia in pregnancy.... A randomized controlled trial was performed in which participants with anemic (hemoglobin <11 g/dL and hematocrit <33%) were allocated to receive either 2 infusions of 510 mg of intravenous ferumoxyto... There were 124 participants (N=62 per group). In the intravenous iron group, the mean change in hemoglobin was 1.86 g/dL (95% confidence interval, 1.57 g/dL-2.14 g/dL) and in the oral group was 0.79 g... Intravenous ferumoxytol was well tolerated, and it was associated with statistically significant increases in maternal hemoglobin, hematocrit, iron, and ferritin compared to oral ferrous sulfate....

Pregnancy Female Humans Ferrosoferric Oxide Anemia, Iron-Deficiency +5 autres

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.

08 2023

DOI: 10.1177/02698811231171531 PMID: 37194253

Ketamine is an emerging treatment for treatment-resistant depression (TRD) associated with rapid and robust improvements in depressive symptoms and suicidality. However, the efficacy and safety of ket... In this retrospective analysis, TAY patients (... A significant main effect of infusions on reduction of total QIDS-SR16 (... Ketamine was associated with comparable clinical benefits, safety, and tolerability in a TAY sample as compared to a matched GA TRD sample....

Adult Humans Adolescent Young Adult Middle Aged +5 autres

Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects.

03 03 2023

DOI: 10.1186/s40360-023-00652-3 PMID: 36869387

Voriconazole is a second-generation triazole that is used to prevent and treat invasive fungal infections. The purpose of this study was to evaluate the pharmacokinetic equivalency of a test formulati... This was a randomized, open-label, single-dose, two-treatment, two-sequence, two-cycle, crossover phase I trial. The 48 subjects were equally divided into 4 mg/kg and 6 mg/kg groups. Within each group... The 90% confidence intervals (CIs) of the ratio of geometric means (GMRs) of C... In both 4 mg/kg group and 6 mg/kg group, equivalent pharmacokinetic characteristics that satisfied the criteria of bioequivalence for both test and reference formulations of Voriconazole.... NCT05330000 (15/04/2022)....

Humans Chromatography, Liquid East Asian People Infusions, Intravenous Tandem Mass Spectrometry +1 autres

Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles.

25 Jul 2023

DOI: 10.1016/j.ijpharm.2023.123091 PMID: 37268032

Subvisible particles generated during the preparation or administration of biopharmaceuticals might increase the risk of immunogenicity, inflammation, or organ dysfunction. To investigate the impact o...

Infusions, Intravenous Pharmaceutical Preparations Silicone Oils Antibodies, Monoclonal Syringes

Usefulness of the perfusion index for monitoring the response to intravenous ketamine infusion therapy in patients with complex regional pain syndrome.

06 2023

DOI: 10.1111/papr.13215 PMID: 36840382

This study was performed to compare the perfusion index (PI) between affected and unaffected limbs in patients with complex regional pain syndrome (CRPS); it also evaluated the usefulness of the PI fo... In total, 46 patients with CRPS in one arm or leg were enrolled in this study. The PIs of the unaffected (PI... PI... The PI significantly differed between affected and unaffected limbs in patients with CRPS. The PI may be useful for monitoring the response to intravenous ketamine therapy in patients with CRPS....

Humans Ketamine Analgesics Perfusion Index Complex Regional Pain Syndromes +1 autres

An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.

Jan 2023

DOI: 10.1007/s40265-022-01819-8 PMID: 36607589

Posaconazole is widely used for the prophylaxis and treatment of invasive fungal diseases. Because of the limited and variable absorption of the initially available oral suspension, a delayed-release ... This study aimed to characterize the pharmacokinetics, including the absolute oral bioavailability, of all posaconazole formulations in healthy volunteers.... Data from 182 healthy volunteers with 3898 densely sampled posaconazole concentrations were pooled from eight phase I clinical studies on the three formulations of various single and multiple dosage r... A two-compartment model with respectively, four and eight absorption transit compartments, best described the profiles of the oral suspension and delayed-release tablet. For the suspension, both a foo... For both oral posaconazole formulations, we quantified bioavailability and absorption rate, including food effects, in healthy volunteers. The pharmacokinetic superiority of the delayed-release tablet...

Humans Infusions, Intravenous Antifungal Agents Healthy Volunteers Triazoles +5 autres

Stability of benzylpenicillin for continuous intravenous infusions: An isotonic formulation for therapeutic use and a low-dose formulation for clinical trial.

Sep 2022

DOI: 10.1016/j.jiac.2022.04.016 PMID: 35637131

The objectives of this study were to develop a stability-indicating high performance liquid chromatography (HPLC) assay for benzylpenicillin (BPC) in pharmaceutical fluids, and to investigate the stab... The stability of isotonic BPC solutions containing 3.4 or 7.2 mg/mL sodium citrate was compared against contemporary hypertonic solutions. The HPLC assay was shown to be stability-indicating following... After 7 d storage at 4 °C and 24 h at 35 °C, the concentrations of isotonic BPC 30 mg/mL solutions containing 3.4 and 7.2 mg/mL sodium citrate were 96% and 95% respectively, compared to day 0. After 3... The isotonic BPC 30 mg/mL formulation is simple to prepare and may offer clinical benefits in settings where hypertonic solutions are problematic. This study provides assurance that high- and low-dose...

Drug Stability Humans Hypertonic Solutions Infusions, Intravenous Isotonic Solutions +3 autres

Franchises et coassurance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Sources (5801 au total)